Atlas Trials

A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain

Clinical trial NCT00301223 · COMPLETED

Trial details

NCT number
NCT00301223
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neuropathic Pain
Start date
2006-02-01
Enrollment
309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.